Arrevus Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients (NCT05105035) | Arrevus Inc. | 2022-06-14 |
Track Arrevus Inc. automatically
Every clearance here is in the API, with alerts when new ones post.